Microsomal metabolism of quinifuryl — a nitrofurylethenyl-quinolone antiseptic possessing antitumor activityin vitro

  • I. A. Degterev
  • P. C. L. Nogueira
  • A. J. Marsaioli
  • A. E. Verces
Article

Summary

Quinifuryl, 2-(5′-nitro-2′-furanyl)ethenyl-4-{N-[4′-(N,N-diethylamino)-1′-methylbutyl] carbamoyl} quinoline, is a representative of a family of nitrofuran-ethenyl-quinoline antibiotics synthesized in the USSR by Dr N.M. Sukhova. The drug has been shown to be an effective cytostatic and radiosensitizer towards cancer cells in culture. While rapid metabolic consumption of these drugs by liver tissue has been shown, none of the drug metabolites have been isolated and characterized. Here, we present the results of experiments focusing on the isolation and characterization of quinifuryl metabolites. A pyridine derivative was the sole product detected and characterized by GC-MS analysis. An alteration of quinifuryl metabolism by peroxynitrite formed during the metabolism of the drug was assumed to be responsible for an unexpectedly high drug decomposition.

Keywords

Quinifuryl microsomal metabolism antitumor activity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Voronina S.S., Tatarskaya N.K., Degterev I.A., Serebrianiy A.M., Pelevina I.I., Sukhova N.M. (1985): Radiosensitizing activity and metabolism of some nitrofuran derivatives. 1. M-106. Radiobiology (Rus.), 25: 748–751.Google Scholar
  2. 2.
    Verovskiy V.N., Degterev I.A., Sukhova N.M., Buzukov A.A., Leonova E.Yu., Tatarskaya N.K. (1990): Interrelation between structure, microsomal metabolizing activation, mouse toxicity, cytotoxicity and antitumor activity of heterocyclic-and nitroheterocyclic compounds.In vitro andin vivo study. Pharm. Chem. J. (Rus.), 24: 20–24.CrossRefGoogle Scholar
  3. 3.
    Degterev I.A., Buzukov A.A., Tatarskaya N.K., Leonova E.Yu., Sukhova N.M. (1990): Metabolism of heterocyclic compounds in mouse liver microsomes. Pharm. Chem. J. (Rus.), 24: 9–16.Google Scholar
  4. 4.
    Degterev I.A., Tatarskaya N.K., Zaikov G.E. (1993): Kinetics and mechanisms of microsomal metabolism of nitroheterocyclic compounds — 5-nitrofuran and 1-nitroacridine derivatives — and relationship with biological activity of these compounds. In: Todorov I.N., Degterev I.A., Zaikov G.E. (Eds) Bioactive Compounds: Biotransformation and Biological Action. New York: NOVA Science, 155–200.Google Scholar
  5. 5.
    McCalla D.R. (1979): Nitrofurans. In: Hahn F.E. (Ed.) Antibiotics, Vol. 5. New York: Springer, 176–213.Google Scholar
  6. 6.
    Josephy P.D., Mason R.P. (1985): Nitroimidazoles. In: Anders M.W. (Ed.) Bioactivation of Foreign Compounds. New York: Academic Press, 161–222.Google Scholar
  7. 7.
    Degterev I.A., Buzukov A.A., Sharf V.G., Popov K.N., Serebrianiy A.M., Zaikov G.E. (1986): Comparative study ofin vitro ledakrine metabolism in microsomes of EAC-cells and mouse liver. Pharm. Chem. J. (Rus.), 20: 412–417.CrossRefGoogle Scholar
  8. 8.
    Degterev I.A., Tatarskaya N.K., Zaikov G.E. (1989): Spectral investigation of quinifur biotransformation mechanism. Pharm. Chem. J. (Rus.), 23: 664–667.Google Scholar
  9. 9.
    Iliasova V.B., Buzukov A.A., Tabak M., Degterev I.A. (1994): On the mechanism of metabolic denitration of nitroheterocyclic compounds. Biophysics (Rus.), 39: 219–225.Google Scholar
  10. 10.
    Buzukov A.A., Iliasova V.B., Tabak M., Tatarskaya N.K., Degterev I.A. (1995): Metabolic denitration of quinifuryl and nitracrine in mouse liver homogenate. Pharm. Chem. J. (Rus.), 29: 3–8.Google Scholar
  11. 11.
    Buzukov A.A., Il’asova V.B., Tabak M., Meirelles N.C., Degterev I.A. (1996): An ESR and spectrophotometric study of the denitration of nitroheterocyclic drugs by liver homogenates and their metabolic consumption by liver microsomes from cytochrome P-450-induced mice. Chem. Biol. Interact., 100: 113–124.CrossRefPubMedGoogle Scholar
  12. 12.
    Kaiser J-P., Feng Y., Bollag J-M. (1996): Microbial metabolism of pyridine, quinoline, acridine, and their derivatives under aerobic and anaerobic conditions. Microbiol. Rev., 60: 483–498.PubMedGoogle Scholar
  13. 13.
    Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulos H., Beckman J.S. (1992): Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol., 5: 834–842.CrossRefPubMedGoogle Scholar
  14. 14.
    Reigh G., McMahon H., Ninomiya S. (1996): Cytochrome P450 species involved in the metabolism of quinoline. Carcinogenesis, 17: 1989–1996.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1999

Authors and Affiliations

  • I. A. Degterev
    • 3
    • 2
  • P. C. L. Nogueira
    • 1
  • A. J. Marsaioli
    • 1
  • A. E. Verces
    • 3
  1. 1.Instituto de QuímicaUNICAMPCampinasBrasil
  2. 2.Institute of Biochemical PhysicsRussian Academy of SciencesMoscowRussia
  3. 3.Department of Clinical Pathology, Faculty of Medical SciencesUNICAMPXampinasBrazil

Personalised recommendations